Oxford University Vaccine Trial for Coronavirus Put on Hold after Participant Falls Sick

Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been paused due to a suspected serious adverse reaction in a participant in the United Kingdom, according to media reports.

Slideshow

The Killid Group

9 Sep 2020

Oxford University Vaccine Trial for Coronavirus Put on Hold after Participant Falls Sick

Social Media

The pharmaceutical company, AstraZeneca, described the pause as a “routine” hold on in the case of “an unexplained illness”.

The outcome of vaccine trials is being closely watched around the world.

The AstraZeneca-Oxford University vaccine is seen as a strong competitor among dozens being developed globally.

More than 27.5 million people around the world have been diagnosed with the coronavirus and 897,383 have died. More than 18.5 million people have recovered.

Follow TKG on Twitter & Facebook